Patent Owner Precluded from Asserting in Litigation Claims Obtained Through Ex Parte Reexamination

Oct 21, 2019

Reading Time : 2 min

In 2014, Plaintiffs sued Defendants in district court for infringement of a patent directed to “mobile tethering” technology. In response, Defendants sought IPR, challenging the patentability of each of the claims that Plaintiffs asserted in their infringement contentions. The court then stayed the patent infringement action pending the Board’s resolution of the IPR. Ultimately, the Board found all challenged claims unpatentable except for one. Plaintiffs appealed the Board’s decision to the Federal Circuit. While their appeal was pending, Plaintiffs sought ex parte reexamination of the patent at issue in the IPR, and successfully obtained new claims through the reexamination process. With their new claims in hand, Plaintiffs sought leave from the court to amend their infringement contentions to add the newly acquired claims.

The court, applying a local rule that requires a party to show “good cause” to amend infringement contentions, denied Plaintiffs’ request. In doing so, the court explained that it had stayed the infringement action because of the possibility of “substantially streamlin[ing]” the case if the Board found unpatentable some or all of the claims at issue in the IPR. And that is exactly what happened. The IPR resulted in all but one claim surviving. The court found that allowing Plaintiffs to “re-expand the scope of the case, dramatically, by asserting what could be [numerous] claims generated in the reexamination” would render the stay “essentially pointless”—a result the court did not intend.

In analyzing whether “good cause” exists for Plaintiffs to amend their infringement contentions, the court determined that the two factors—namely, (1) whether the moving party was diligent in moving to amend its contentions, and (2) whether the non-moving party would suffer prejudice if leave to amend were granted—both weighed against allowing the amendment. Regarding diligence, the court first explained that Plaintiffs are not automatically entitled to amend their contentions simply because they obtained new claims through reexamination. The court further noted that, because Plaintiffs failed to present to the court the new infringement contentions they are seeking to add, the court cannot ascertain how the new contentions differ from the initial contentions or when any newly-accused products entered the market. The court also found that Defendants would be unduly prejudiced by the amendment because they will have to “devote extensive time and resources to litigate [numerous] new claims” after the case had already been “substantially and successfully narrowed through years of PTAB proceedings.” The court noted that “judicial economy” weighs against allowing Plaintiffs to essentially start the case over with “scores of new claims.”

Practice Tip: Because ex parte reexamination does not reset the one-year deadline for filing a petition for IPR, new claims obtained through reexamination may be immune from IPR attacks. See Apple Inc., v. IXI IP, LLC, IPR2019-00124, -00125, -00139, -00140, -00141, -00181 (PTAB June 3, 2019) (Tierney) which we covered in an earlier post in IP Newsflash. However, patent owners seeking to add claims obtained through reexamination to a district court litigation must recognize that amendment of infringement contentions is not automatic and instead carries a burden that may not be easily met.

IXI Mobile (R&D) Ltd. et al. v. Samsung Electronics Co., Ltd. et al., 4:15-cv-03752 (N.D. Cal. October 11, 2019) (Haywood S. Gilliam, Jr.)

Share This Insight

Previous Entries

IP Newsflash

December 18, 2025

The Federal Circuit recently vacated a $20 million jury verdict in favor of a patentee and remanded with instructions to dismiss the case for lack of subject matter jurisdiction, finding that the patentee did not own the asserted patents at the time it filed suit and therefore lacked standing.

...

Read More

IP Newsflash

December 17, 2025

The Federal Circuit recently affirmed a Patent Trial and Appeal Board decision finding claims that had been subject to an ex parte reexamination unpatentable. As a threshold issue, the court held that IPR estoppel under 35 USC § 315(e)(1) does not apply to ongoing ex parte reexaminations. Accordingly, the Patent Office did not err in continuing the reexamination after issuing final written decisions in co-pending IPRs.

...

Read More

IP Newsflash

December 15, 2025

The District of Delaware recently denied a defendant’s motion to dismiss plaintiff’s demand for enhanced damages based on willful infringement pursuant to 35 U.S.C. § 284, explaining that neither a demand for damages under § 284 nor an accusation of willful infringement amount to a claim for relief that can be subject to dismissal under Rule 12(b)(6).

...

Read More

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.